Viridian Therapeutics
VRDN
$13.45
Share price
-8.07%
Change (1 day)
-41.29%
Change (1 year)
Categories
Viridian Therapeutics (VRDN) - Net assets
Net assets on the balance sheet as of December 2023 : $0.44 B
According to Viridian Therapeutics's latest financial reports the company has $0.44 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Viridian Therapeutics - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.44 B | 11.89% |
| 2022-12-31 | $0.39 B | 110.46% |
| 2021-12-31 | $0.18 B | 56.38% |
| 2020-12-31 | $0.12 B | 661.95% |
| 2019-12-31 | $15.75 M | -69.32% |
| 2018-12-31 | $51.34 M | 33.33% |
| 2017-12-31 | $38.51 M | -11912.88% |
| 2016-12-31 | $-0.33 M | -103.13% |
| 2015-12-31 | $10.41 M | 73.76% |
| 2014-12-31 | $5.99 M | -125.08% |
| 2013-12-31 | $-23.89 M | 11.4% |
| 2012-12-31 | $-21.45 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.22 B | -49.30% | 🇺🇸 USA |